Filing step-change
GENPHARMA · 2026-08
Quarterly observations that moved versus the prior period in 2026-08. Facts only — not a call to act.
Narrative date 2026-08-31 · Evidence medium
Genpharma's Gross Margin accelerated to 7.54%, up from 0.57%.
Raw Evidence
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 7.54 % | 0.57 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 0.57 % | 0.37 | ▲ |
Cite this
Source: Samhati filing step-change for GENPHARMA (2026-08). Observation: Genpharma's Gross Margin accelerated to 7.54%, up from 0.57%. Evidence quality: medium. Not investment advice — no buy, sell, or hold recommendation. Full narrative (Pro): https://samhati.ai/pricing Page: https://samhati.ai/stock/genpharma/q/2026-08
Other periods